跳至主要内容
临床试验/NCT02156024
NCT02156024Unknown4 期

The Short-term Efficacy of Gastrodia and Uncaria Drink in Treating Hypertension

Shanghai Institute of Hypertension1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2014年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
400
试验地点
1
主要终点
blood pressure

研究概览

简要总结

The purpose of this study is

  1. To determine whether the Gastrodia and Uncaria Drink is effective in the treatment of masked hypertensive patients below 70 years.
  2. To find out the suitable groups for the Gastrodia and Uncaria Drink treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age between 18 to 70 years
  • didn't use any anti-hypertension drugs within 2 weeks
  • stage 1 masked hypertensive patients, which means clinic blood pressure<140/90 mmHg,however the daytime(8:00-18:00) 24h ambulatory blood pressure between 135/85 and 150/95mmHg
  • be willing to participate in the trials and able to finish clinic visit

排除标准

  • secondary hypertension
  • be allergic to the clinical trial medicine
  • occurrence of stroke, CKD, myocardial infarction within 2 years
  • dysfunction of liver or kidney and fundus hemorrhage
  • arrhythmia
  • ALT, AST, TBL upper the twice of normal range, Scr≥2.0mg/dl, K+≥5.5mmol/L, Urine protein≥2+
  • psychiatric disorders
  • pregnant, breastfeeding
  • other serious conditions in which is not fit for the study

研究组 & 干预措施

Gastrodia and Uncaria Drink

Active Comparator

Gastrodia and Uncaria Drink, 1 dose at a time, twice a day, duration: 4 weeks

干预措施: Gastrodia and Uncaria Drink (Drug)

结局指标

主要结局

blood pressure

时间窗: March 1,2015

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Cheng Yibang

master

Shanghai Institute of Hypertension

研究点 (1)

Loading locations...

相似试验